Percentages of patients receiving etanercept using disease-modifying antirheumatic drugs (DMARD) and nonsteroidal antiinflammatory drugs (NSAID), at various times during 24 months of followup.
| Baseline | 3 Months | 12 Months | 24 Months | |
|---|---|---|---|---|
| No. concomitant DMARD | ||||
| 0 | 21 | 20 | 35 | 33 |
| 1 | 48 | 67 | 60 | 61 |
| 2 | 31 | 14 | 6 | 6 |
| 3 | 0 | 0 | 0 | 0 |
| NSAID use | ||||
| Continuously | 47 | 14 | 17 | 12 |
| Temporarily as needed | 39 | 59 | 50 | 55 |
| Not used | 15 | 28 | 33 | 33 |